# A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department

> **NCT06156436** · — · COMPLETED · sponsor: **ResApp Health Limited** · enrollment: 75 (actual)

## Conditions studied

- Croup
- Bronchiolitis
- Asthma in Children
- Reactive Airway Disease
- Pneumonia
- Lower Respiratory Tract Infection

## Interventions

- **DEVICE:** ResAppDx v.20

## Key facts

- **NCT ID:** NCT06156436
- **Lead sponsor:** ResApp Health Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-02-29
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06156436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06156436, "A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06156436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*